Andreas G. Niethammer
- Immunology top 2%
- Immunotherapy and Immune Responses 16
- T-cell and B-cell Immunology 5
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 4
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Biotechnology top 2%
- Cancer Research and Treatments 10
-
- Renal cell carcinoma treatment 4
-
- Angiogenesis and VEGF in Cancer 6
- RNA Interference and Gene Delivery 4
- Co-authors
- Ralph A. ReisfeldRong XiangArgyrios N. TheofilopoulosNorbert WagnerRoberto BaccalàBrian R. LawsonWolfgang DummerBernard Escudier
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Clinical Investigation (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Andreas G. Niethammer
44 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 101
- Immunology 980
- Oncology 947
- Cancer Research 425
- Biotechnology 243
- Pulmonary and Respiratory Medicine 725
Countries citing papers authored by Andreas G. Niethammer
This map shows the geographic impact of Andreas G. Niethammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas G. Niethammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas G. Niethammer more than expected).
Fields of papers citing papers by Andreas G. Niethammer
This network shows the impact of papers produced by Andreas G. Niethammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas G. Niethammer. The network helps show where Andreas G. Niethammer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas G. Niethammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 12 | |
| 2 | 2015 | 3 | |
| 3 | 2014 | 47 | |
| 4 | 2013 | 5 | |
| 5 | 2012 | 48 | |
| 6 | 2011 | 93 | |
| 7 | 2008 | 64 | |
| 8 | 2007 | 70 | |
| 9 | 2007 | 25 | |
| 10 | 2006 | 30 | |
| 11 | 2005 | 10 | |
| 12 | 2005 | 27 | |
| 13 | An oral vaccine against the tumor-stromal antigen FAP (fibroblast activation protein) inhibits growth of chemo-resistant murine colon-carcinoma | 2004 | 1 |
| 14 | 2004 | 17 | |
| 15 | 2004 | 26 | |
| 16 | 2002 | 310 | |
| 17 | 2002 | 255 | |
| 18 | 2001 | 79 | |
| 19 | MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する | 2001 | 1 |
| 20 | 1999 | 19 |
About Andreas G. Niethammer
Andreas G. Niethammer is a scholar working on Biotechnology, Immunology and Oncology, having authored 46 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), Cancer Research and Treatments (10 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), T-cell and B-cell Immunology (5 papers), Renal cell carcinoma treatment (4 papers), RNA Interference and Gene Delivery (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Immunology (980 citations), Oncology (947 citations) and Cancer Research (425 citations). Andreas G. Niethammer has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Ralph A. Reisfeld, Rong Xiang, Argyrios N. Theofilopoulos, Norbert Wagner, Roberto Baccalà, Brian R. Lawson, Wolfgang Dummer, Bernard Escudier, Ursula Pertl and Hariharan Subramanian. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Investigation, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.